31 – 40 of 64
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
A systematic analysis of commonly used antibodies in cancer diagnostics
(
- Contribution to journal › Article
-
Mark
Peroxiredoxin-1 protects estrogen receptor alpha from oxidative stress-induced suppression and is a protein biomarker of favorable prognosis in breast cancer
(
- Contribution to journal › Article
- 2013
-
Mark
Nuclear T-STAR Protein Expression Correlates with HER2 Status, Hormone Receptor Negativity and Prolonged Recurrence Free Survival in Primary Breast Cancer and Decreased Cancer Cell Growth In Vitro.
(
- Contribution to journal › Article
-
Mark
Decreased expression of RNA-binding motif protein 3 correlates with tumour progression and poor prognosis in urothelial bladder cancer
(
- Contribution to journal › Article
-
Mark
Podocalyxin-like protein expression in primary colorectal cancer and synchronous lymph node metastases
(
- Contribution to journal › Article
-
Mark
Targeting HMG-CoA reductase with statins in a window-of-opportunity breast cancer trial.
(
- Contribution to journal › Article
-
Mark
Systematic antibody generation and validation via tissue microarray technology leading to identification of a novel protein prognostic panel in breast cancer
(
- Contribution to journal › Article
-
Mark
Contribution of Antibody-based Protein Profiling to the Human Chromosome-centric Proteome Project (C-HPP)
(
- Contribution to journal › Article
-
Mark
CDK-mediated activation of the SCFFBXO28 ubiquitin ligase promotes MYC-driven transcription and tumourigenesis and predicts poor survival in breast cancer
(
- Contribution to journal › Article
- 2012
-
Mark
Expression of the global regulator SATB1 is an independent factor of poor prognosis in high grade epithelial ovarian cancer
(
- Contribution to journal › Article